Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death.
AUTHORS
van der Heijden
YF ,
Maruri
F ,
Blackman
A ,
Holt
E ,
Warkentin
JV ,
Shepherd
BE ,
Sterling
TR ,
. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2012 9 1; 16(9). 1162-7
- PMID: 22794509 [PubMed].
- PMCID: PMC3981533.
- NIHMSID: NIHMS451011
ABSTRACT
Fluoroquinolone (FQ) exposure before tuberculosis (TB) diagnosis is common, but its effect on outcomes, including mortality, is unclear.
Fluoroquinolone (FQ) exposure before tuberculosis (TB) diagnosis is common, but its effect on outcomes, including mortality, is unclear.
Tags: Alumni Publications 2012